ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tiziana Life Sciences signs manufacturing deal with STC Biologics
July 01, 2020UK-based biotechnology firm Tiziana Life Sciences has executed an agreement with STC Biologics for the manufacture of TZLS-501 for clinical studies in Covid-19 patients. -
Tiziana develops delivery tech for COVID-19 treatment
April 10, 2020Tiziana Life Sciences says it has developed an investigational new technology that it hopes will ultimately be used to treat COVID-19 infections. -
Tiziana Life Sciences to expedite development of TZLS-501 for COVID-19
March 12, 2020TZLS-501 is a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients infected with coronavirus COVID-19.
Pharma Sources Insight January 2025
